- Home
- Equipment
- south korea
- tyrosine kinase inhibitor
Refine by
Tyrosine Kinase Inhibitor Equipment Supplied In South Korea
3 equipment items found
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
The existence of KRAS mutations is often related with a prognostic marker to drug response. For example, KRAS mutation is considered a strong prognostic marker for drug response of tyrosine kinase inhibitors such as Gefitinib (Iressa) or Erlotinib (Tarceva). Recently, KRAS mutation is often detected in colorectal cancer and may be related with ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
So the prognosis tends to be bad. It is known that the patients with EGFR mutation show very high drug responses against EGFR tyrosine kinase inhibitor (TKI) such as Gefitinib (Iressa, AstraZenca) and Erlotinib (Tarceba, Roche). We expect that genotyping EGFR genes of the lung cancer patients enables predicting drug response before treatment and ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Chemotherapy drugs have many side effects such as reduction in white blood cells, hair loss, vomiting because they attack rapidly growing cells without separating cancer cells from normal cells. However targeted therapy drugs have less side effects because they detect and attack specific targets that exist only in cancer ...